Recent preclinical andclinical studies have demonstrated the significant potential of GLP-1RAs in slowing the progression of neurodegenerative diseases [16, 17]
Recent studies, such as the SUSTAIN trial, have indicated promising cardiovascular benefits associated with Semaglutide use
This prevents overlapping doses and reduces the likelihood of dose-dependent adverse effects, particularly gastrointestinal symptoms which are the most common reason for treatment discontinuation
The authors hypothesized that early life adversity may alter oral microbiome composition, which can shift to gut via saliva, potentially creating a pro-inflammatory state that increases vulnerability to PTSD following subsequent trauma exposure (Malan-Muller et al., 2022)
If you have insurance but it doesnt cover Zepbound, your card savings are subject to a maximum monthly savings based on the difference between the retail price and $499
Phase Dual escalation 1 Weeks 13-16 Retatrutide 8 mg/week Cagrilintide 0.5 mg/week Notes GI effects often peak here